On September 10, beginning at 4 ET (webcastlink), Soligenix (NASDAQ:SNGX) will be hosting an investor webcast event on the use of its thermostabilized glycoprotein vaccine platform for the development of a COVID-19 vaccine, called CiVax.
https://seekingalpha.com/news/3611419-soligenix-to-host-investor-webcast
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.